Filing Details
Jaguar Health, Inc. (NASDAQ:JAGX) filed a Form 8-K with the Securities and Exchange Commission on June 25, 2026, disclosing a material event.
8k filedNASDAQ:JAGX
Jaguar Health, Inc. (JAGX) Reports Material Event to SEC
Filing Details Jaguar Health, Inc. (NASDAQ:JAGX) filed a Form 8-K with the Securities and Exchange Commission on June 25, 2026, disclosing a material event. Market Context Jaguar…
Market Context
Jaguar Health, Inc.'s stock currently trades at $2.73 with a market capitalization of $3.1M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Jaguar Health, Inc.'s stock.
All SEC filings for Jaguar Health, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View JAGX Stock Page
Frequently Asked Questions
Where can I read JAGX's SEC filings?
Browse all filings on our JAGX SEC filings page.
What types of SEC filings does Jaguar Health, Inc. file?
Public companies like Jaguar Health, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.